Method that transports microbes through the stomach to the intestine may benefit human health

September 14, 2016 by Anne Trafton, Massachusetts Institute of Technology
A team of MIT scientists has developed a strategy for delivering large numbers of beneficial bacterial to the human gut. The strategy involves coating bacteria with polymer layers that protect them from the acids and bile salts found in the digestive tract. Credit: Second Bay Studios

The human digestive tract contains trillions of bacteria, many of which help digest food and fight off harmful bacteria. Recent studies have shown that some of these bacteria may influence, for better or worse, human diseases such as diabetes, heart disease, and cancer.

As scientists have learned more about these bacteria, many have raised the possibility that manipulating these populations, known collectively as the microbiome, could improve human health.

Looking toward that future, a team of MIT scientists has developed a strategy for delivering large numbers of beneficial bacterial to the .

"Once the microbiome is better understood, we can use this delivery platform to target certain areas and introduce certain species there," says Ana Jaklenec, a research scientist at MIT's Koch Institute for Integrative Cancer Research and one of the senior authors of a paper describing this approach in the Sept. 12 issue of the journal Advanced Materials.

Jaklenec and colleagues developed a way to coat bacteria with polymer layers that protect them from the acids and bile salts found in the digestive tract. When the microbes reach the intestine, they attach to the intestinal lining and begin reproducing.

"The bacteria are delivered and they adhere to the intestinal wall, where they survive much better than noncoated bacteria," says Koch Institute postdoc Aaron Anselmo, the paper's first author.

Robert Langer, the David H. Koch Institute Professor at MIT and a member of the Koch Institute, is also a senior author of the paper. Other authors are postdoc Kevin McHugh and technical assistant Jamie Webster.

Beneficial bacteria

Doctors sometimes recommend beneficial bacteria, also known as probiotics, for patients suffering from GI illnesses such as colitis and Crohn's disease. However, these over-the-counter probiotic supplements may contain varying amounts of bacteria, and may include cells that are no longer viable. Furthermore, these probiotics have no protective coating, so they can be damaged by acid in the stomach before reaching the intestines.

The MIT team decided to try coating bacterial cells with thin layers of polysaccharides, or sugars. They chose two biodegradable polysaccharides known as chitosan and alginate, which have been previously used in other oral delivery technologies. These polysaccharides are known to be mucoadhesive, meaning that they will stick to the mucosal lining of the intestines.

In this study, the researchers demonstrated their technique with a strain of bacteria known as Bacillus coagulans, which is sometimes used to treat colitis and irritable bowel syndrome. This strain is not normally found in the human gut but helps to alleviate abdominal pain and bloating by producing lactic acid.

To coat the bacteria, the researchers used a technique known as layer-by-layer encapsulation, achieved by depositing thin, alternating layers of positively and negatively charged materials. Bacillus coagulans have a negatively charged surface, so the researchers first applied a layer of chitosan, which is positively charged, followed by a layer of negatively charged alginate. They applied a total of four layers (two of each polysaccharide).

"It's a reasonably gentle process, so you're not destroying the bacteria," Jaklenec says.

This results in a very thin, gel-like coating that individually encapsulates each bacterial cell. In tests in mice, the researchers showed that this coating protects the cells from acid in the stomach, as well as bile salts. Once the cells reach the intestines, they settle in and begin replicating. The researchers found that the coated bacteria had a survival rate six times greater than that of uncoated bacteria.

Oral delivery

This kind of oral probiotic delivery could replace an experimental treatment known as fecal transplant, which is now in clinical trials to treat infections of Clostridium difficile, which can produce severe inflammation of the colon. Fecal transplant involves isolating from stool samples of healthy people and delivering them to a patient by enema or colonoscopy.

For medicinal use, the coated bacteria could be easily packaged into a capsule or made into a dried powder that could be mixed into a drink, the researchers say.

This strategy should work with any kind of that has a charged surface, whether positive or negative, and it could also work with other microbes such as yeast, the researchers say. They are now working on making the coatings responsive to acidity levels, which could make it easier to target them to other parts of the GI tract, such the colon. They are also interested in adapting this approach to deliver microbes to other parts of the body such as the skin or mouth.

Explore further: Gut bacteria affect immune recovery in HIV patients, study finds

More information: Aaron C. Anselmo et al. Layer-by-Layer Encapsulation of Probiotics for Delivery to the Microbiome, Advanced Materials (2016). DOI: 10.1002/adma.201603270

Related Stories

When beneficial bacteria knock but no one is home

May 9, 2016

The community of beneficial bacteria that live in our intestines, known as the gut microbiome, are important for the development and function of the immune system. There has been growing evidence that certain probiotics—therapies ...

Recommended for you

Coffee-based colloids for direct solar absorption

March 22, 2019

Solar energy is one of the most promising resources to help reduce fossil fuel consumption and mitigate greenhouse gas emissions to power a sustainable future. Devices presently in use to convert solar energy into thermal ...

EPA adviser is promoting harmful ideas, scientists say

March 22, 2019

The Trump administration's reliance on industry-funded environmental specialists is again coming under fire, this time by researchers who say that Louis Anthony "Tony" Cox Jr., who leads a key Environmental Protection Agency ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.